0 NASDAQ Companies - October 11, 2024Paltalk Holdings Announces Judge Enters Final Judgment in Connection With Cisco Jury VerdictJERICHO, N.Y. , Oct. 11, 2024 (GLOBE NEWSWIRE) — Paltalk, Inc. (“Paltalk,” the “Company,” “we,” our,” or “us”) (NASDAQ: PALT), […]Read More
0 NYSE Companies - October 11, 2024Par Pacific Announces Third Quarter 2024 Earnings Release and Conference Call ScheduleHOUSTON, Oct. 11, 2024 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will […]Read More
0 Canadian Stock Exchange News - October 11, 2024Global Uranium Corp. Prepares to Commence Ground-Based Radiometric Survey on Wyoming ProjectsCALGARY, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTCQB: GURFF | FRA: Q3J) (the […]Read More
0 NASDAQ Companies - October 11, 2024Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience MeetingMELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the […]Read More
0 NASDAQ Companies - October 11, 2024Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health CongressNEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing […]Read More
0 NYSE Companies - October 11, 2024Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx HealthTAMPA, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet […]Read More
0 NASDAQ Companies - October 11, 2024AGBA ADVANCES TOWARD COMPLETION OF THE TRILLER MERGERAGBA Group Holding Limited (Nasdaq: AGBA) (“AGBA” or the “Company”) and Triller Corp. (“Triller”), today announced that their merger is […]Read More
0 NASDAQ Companies - October 11, 2024Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology– Treatment with denifanstat achieved statistically significant and clinically meaningful improvements in disease activity, MASH resolution and fibrosis –– Results […]Read More
0 NASDAQ Companies - October 11, 2024Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be […]Read More
0 TSX Venture News - October 11, 2024Jo-Jo Capital Canada Ltd. Announces Termination of Proposed Qualifying TransactionTORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Jo-Jo Capital Canada Ltd. (the “Company“) (TSXV: JOJO.P) a capital pool company pursuant […]Read More